Glipizide Tablets

Glipizide Tablets

$3.00

Pure Glipizide 5mg film-coated tablets, 30-count box, manufactured by Hainan Zanbang Pharmaceutical Co., Ltd. Trusted for laboratory research on sulfonylurea mechanisms and antidiabetic studies.
 For laboratory research or analytical purposes only – Not for human consumption or therapeutic use.

EMI starting from $0.00/month - View Plans
Compare

Description

Glipizide Tablets Description

Product name: Glipizide tablets (Mepirida)
Packaging specifications: 5mg*30 tablets  Product dosage form: tablets ? Packaging unit: box
Approval number: National Medicine Standard H10930076  Drug standard code: 86905838000102
Manufacturer: Hainan Zanbang Pharmaceutical Co., Ltd.
Product barcode: 6936399586631

Glipizide, sold under brand names like Glucotrol, is a second-generation sulfonylurea widely used to treat type?2 diabetes mellitus (T2DM) by increasing insulin secretion through inhibition of pancreatic ATP-sensitive K? channels?globalrph.com+15pubmed.ncbi.nlm.nih.gov+15reddit.com+15. It also enhances peripheral insulin sensitivity and suppresses hepatic glucose output. Research use focuses on insulinotropic effects, cellular mechanisms, and safety profiling?.


 Product Specifications

PropertyDetails
Brand NameMeipida
Generic NameGlipizide Tablets
Strength5mg per tablet
FormFilm-coated tablets
Quantity30 tablets per box
Approval Number (NMPA)H10930076
Pharmaceutical Code86905838000102
ManufacturerHainan Zanbang Pharmaceutical Co., Ltd.
Barcode6936399586631
Storage ConditionsStore in a cool, dry place (15–30°C), protected from light
Shelf Life24 months
Intended UseFor laboratory or analytical use only

 Mechanism of Action & Key Features

  • Beta-Cell Stimulation: Glipizide blocks ATP-sensitive K? channels ? cell depolarization ? Ca²? influx ? increased insulin secretion?.

  • Peripheral & Hepatic Effects: Enhances insulin receptors on muscle, fat, and liver cells; inhibits hepatic gluconeogenesis?.

  • Fast Onset, Moderate Duration: Available in immediate-release form; effect seen within ~30 minutes, lasting up to 24 hours?.

  • Well-Studied Safety: Most common side effects are hypoglycemia, weight gain, gastrointestinal symptoms, and rare cardiac/liver effects?.


 Why Choose Meipida Glipizide?

  • Fully licensed via NMPA (H10930076)

  • Trusted second-generation sulfonylurea, comparable to Glucotrol

  • Accurate dosage and blister-packed for lab precision

  • Ideal for research on pancreatic, hepatic, and metabolic pathways


 Related Research Substances

  • Metformin HCl Tablets (Biguanides)

  • Sitagliptin Phosphate Tablets (DPP?4 inhibitor)

  • Empagliflozin 10?mg Tablets (SGLT?2 inhibitor)


 Summary

Meipida Glipizide 5mg Tablets offer a dependable, research-ready sulfonylurea option. Manufactured in compliance with NMPA regulations, and packed in blisters for accurate dosing—this product supports metabolic, pharmacodynamic, and pharmacokinetic research.
Reminder: strictly for laboratory or analytical use only.

Additional information

Weight1.1 kg
Dimensions18 × 18 × 16 cm

Reviews

There are no reviews yet.

Be the first to review “Glipizide Tablets”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare